Accepted Manuscript An alternative synthesis of the non-small cell lung carcinoma drug afatinib Tatjana Kovacevic, Milan Mesic, Amir Avdagic, Miroslav Zegarac PII: S0040-4039(18)31233-4 DOI: https://doi.org/10.1016/j.tetlet.2018.10.026 Reference: TETL 50336 To appear in: Tetrahedron Letters Received Date: 12 September 2018 Revised Date: 8 October 2018 Accepted Date: 14 October 2018 Please cite this article as: Kovacevic, T., Mesic, M., Avdagic, A., Zegarac, M., An alternative synthesis of the non- small cell lung carcinoma drug afatinib, Tetrahedron Letters (2018), doi: https://doi.org/10.1016/j.tetlet. 2018.10.026 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.